Cargando…

Anti-VEGF Treatment of Diabetic Macular Edema: Two-Year Visual Outcomes in Routine Clinical Practice

PURPOSE: The purpose of this study was to evaluate 2-year visual outcomes in patients with diabetic macular edema (DME) treated with anti-VEGF agents in a routine clinical setting. METHODS: The medical records of patients treated with ranibizumab or aflibercept due to DME at the Eye Hospital, Univer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urbančič, Mojca, Klobučar, Pia, Zupan, Matej, Urbančič, Katja, Lavrič, Alenka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125496/ https://www.ncbi.nlm.nih.gov/pubmed/32280530 http://dx.doi.org/10.1155/2020/6979758

Ejemplares similares

VISUAL OUTCOMES IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT IN ROUTINE CLINICAL PRACTICE
por: Urbančič, Mojca, et al.
Publicado: (2021)

Floating Vitreous Cyst: Two Clinical Cases
por: Lavric, Alenka, et al.
Publicado: (2013)

Dexamethasone implant in the management of diabetic macular edema from clinician’s perspective
por: Urbančič, Mojca, et al.
Publicado: (2019)

Choroidal thickening with serous retinal detachment in BRAF/MEK inhibitor-induced uveitis: A case report
por: Kiraly, Peter, et al.
Publicado: (2022)

Risk of renal damage associated with intravitreal anti-VEGF therapy for diabetic macular edema in routine clinical practice
por: del Cura, Mar Prieto, et al.
Publicado: (2023)

Anti-VEGF for the Management of Diabetic Macular Edema
por: Stefanini, Francisco Rosa, et al.
Publicado: (2014)

Visual Acuity, Retinal Sensitivity, and Macular Thickness Changes in Diabetic Patients without Diabetic Retinopathy after Cataract Surgery
por: Stunf Pukl, Spela, et al.
Publicado: (2017)

Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning
por: Zhang, Ying, et al.
Publicado: (2022)

The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis
por: Hudler, Petra, et al.
Publicado: (2022)

Relationship Between Macular Thickness and Visual Acuity in the Treatment of Diabetic Macular Edema With Anti-VEGF Therapy: Systematic Review
por: Wang, Patrick, et al.
Publicado: (2022)

Iris Ring Melanoma Presenting as Scleral Pigmentation
por: Zupan, Matej, et al.
Publicado: (2022)

Vitreomacular interface after anti-VEGF injections in diabetic macular edema
por: Veloso, Carlos E., et al.
Publicado: (2021)

Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
por: Sorour, Osama A., et al.
Publicado: (2020)

Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study
por: Wirkkala, Joonas, et al.
Publicado: (2022)

Flavoprotein Fluorescence Correlation with Visual Acuity Response in Patients Receiving Anti-VEGF Injection for Diabetic Macular Edema
por: Andrade Romo, Jorge S., et al.
Publicado: (2018)

Outer retinal tubulation in diabetic macular edema following anti-VEGF treatment
por: Al-Halafi, Ali M
Publicado: (2015)

Dexamethasone Implant in Patients with Diabetic Macular Edema Resistant to Anti-VEGF Therapy
por: Nalçacı, Serhad, et al.
Publicado: (2019)

Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review
por: Distefano, Laura N., et al.
Publicado: (2017)

Glycemic Control after Initiation of Anti-VEGF Treatment for Diabetic Macular Edema
por: Oshima, Hideyuki, et al.
Publicado: (2022)

Diabetic macular edema: it is more than just VEGF
por: Singer, Michael A., et al.
Publicado: (2016)

Cross-cultural adaptation and validation of nasal obstruction symptom evaluation questionnaire in Slovenian language
por: Urbančič, Jure, et al.
Publicado: (2016)

The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: A comparative study of two anti-VEGFs
por: Bakbak, Berker, et al.
Publicado: (2016)

Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
por: Garoon, Robert B., et al.
Publicado: (2016)

Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
por: Mira, Filipe, et al.
Publicado: (2017)

Foveal Microvascular Integrity Association With Anti-VEGF Treatment Response for Diabetic Macular Edema
por: Huang, Wei-Hsuan, et al.
Publicado: (2021)

A Flow Cytometric Analysis of Vitreous Inflammatory Cells in Patients with Proliferative Diabetic Retinopathy
por: Urbančič, Mojca, et al.
Publicado: (2013)

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)
por: Blinder, Kevin J, et al.
Publicado: (2017)

Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients
por: Filek, Richard, et al.
Publicado: (2019)

Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment
por: Kwon, Jin-woo, et al.
Publicado: (2018)

Characteristics of diabetic macular edema patients refractory to anti-VEGF treatments and a dexamethasone implant
por: Choi, Moon Young, et al.
Publicado: (2019)

Factors Affecting a Short-Term Response to Anti-VEGF Therapy in Diabetic Macular Edema
por: Usui-Ouchi, Ayumi, et al.
Publicado: (2021)

miRNA Levels as a Biomarker for Anti-VEGF Response in Patients with Diabetic Macular Edema
por: Vader, Maartje J. C., et al.
Publicado: (2021)

Expert Panel Consensus for Addressing Anti-VEGF Treatment Challenges of Diabetic Macular Edema in Spain
por: Fernández-Vigo, José Ignacio, et al.
Publicado: (2022)

Regional Variety of Reduction in Retinal Thickness of Diabetic Macular Edema after Anti-VEGF Treatment
por: Yamada, Yutaka, et al.
Publicado: (2022)

Metformin therapy as a strategy to compensate anti-VEGF resistance in patients with diabetic macular edema
por: Uwimana, Alexandre, et al.
Publicado: (2022)

The role of serum metrics in anti- VEGF treatment for macular edema induced by retinal vein occlusion
por: Wang, Yun-Chang, et al.
Publicado: (2023)

Anti-VEGF Treatment of Diabetic Macular Edema in Denmark: Incidence, Burden of Therapy, and Forecasting Analyses
por: Subhi, Yousif, et al.
Publicado: (2023)

Relationship Between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy
por: Eraslan, Seher, et al.
Publicado: (2020)

New Target for Accurate Terrestrial Laser Scanning and Unmanned Aerial Vehicle Point Cloud Registration
por: Urbančič, Tilen, et al.
Publicado: (2019)

Unraveling the Etiology of Pediatric Vertigo and Dizziness: A Tertiary Pediatric Center Experience
por: Božanić Urbančič, Nina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p0bq1ajsjg6u68bv7esnqk5oah